Viewing Study NCT06180239



Ignite Creation Date: 2024-05-06 @ 7:55 PM
Last Modification Date: 2024-10-26 @ 3:16 PM
Study NCT ID: NCT06180239
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2023-12-22
First Post: 2023-12-04

Brief Title: Segmentectomy vs Lobectomy
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Organization: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Study Overview

Official Title: Different Segmentectomy vs Lobectomy Comparison in NSCLC
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2023-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Actual indications for stage Ia NSCLC patients suggest lobectomy and lymphadenectomy On the other hand recent studies reported non-inferiority of segmentectomy in case of nodule 2cm or with ground glass appearance at computed tomography

However most of these studies did not report specifical analysis on kind of segmentectomy single or multiple and kind of lobectomy Moreover a specific study on solid nodules only is still missing

For these reasons the effectiveness of segmentectomy instead lobectomy for every kind of segment or tumor is still to be defined

Aim of this study is to analyze survival outcome in patients underwent single or multiple segmentectomy compared to lobectomy in stage I non small cell lung cancer
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None